JB/PUT/PFIZER INC/32/0.1/20.09.24 | Market Closed - Swiss Exchange 16:20:00 03/06/2024 BST | ||
| 0.31 CHF | -16.22% |
|
| 1 month | -34.04% | ||
| 3 months | -41.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 0.31 | -16.22% |
| 31/05/24 | 0.37 | -11.90% |
| 29/05/24 | 0.42 | +10.53% |
| 28/05/24 | 0.38 | +8.57% |
Delayed Quote Swiss Exchange
Last update June 03, 2024 at 04:20 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | Bank Julius Bär |
| PFZVJB | |
| ISIN | CH1303724194 |
| Date issued | 23/11/2023 |
| Strike | 32 $ |
| Maturity | 20/09/2024 (109 Days) |
| Parity | 10 : 1 |
| Emission price | 0.37 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.66 CHF |
|---|---|
| Lowest since issue | 0.3 CHF |
| Spread | 0.01 CHF |
| Spread % | 3.23% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Warrants
- PFZVJB Warrant